M&T Bank Corp Has $154,000 Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

M&T Bank Corp reduced its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 39.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 10,288 shares of the medical instruments supplier’s stock after selling 6,629 shares during the quarter. M&T Bank Corp’s holdings in DENTSPLY SIRONA were worth $154,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in XRAY. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of DENTSPLY SIRONA in the first quarter worth $25,000. Colonial Trust Co SC acquired a new position in shares of DENTSPLY SIRONA in the fourth quarter worth $26,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock worth $33,000 after acquiring an additional 1,568 shares during the last quarter. True Wealth Design LLC increased its stake in shares of DENTSPLY SIRONA by 866.7% in the fourth quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier’s stock worth $41,000 after acquiring an additional 1,950 shares during the last quarter. Finally, Quarry LP increased its stake in shares of DENTSPLY SIRONA by 25.7% in the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier’s stock worth $72,000 after acquiring an additional 780 shares during the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $15.68 on Friday. The firm has a market capitalization of $3.12 billion, a price-to-earnings ratio of -3.45, a P/E/G ratio of 1.12 and a beta of 0.94. The company has a current ratio of 1.10, a quick ratio of 0.76 and a debt-to-equity ratio of 0.79. The firm’s 50 day simple moving average is $16.07 and its 200 day simple moving average is $16.27. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $27.95.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating the consensus estimate of $0.29 by $0.14. The business had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The firm’s revenue was down 7.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.42 EPS. As a group, research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.08%. The ex-dividend date was Friday, June 27th. DENTSPLY SIRONA’s dividend payout ratio is presently -14.10%.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several analyst reports. Barrington Research increased their target price on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an “outperform” rating in a research report on Monday, May 12th. Piper Sandler decreased their price target on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a report on Wednesday, April 30th. Wall Street Zen upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Sunday, July 13th. UBS Group decreased their price target on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating for the company in a report on Friday, May 9th. Finally, Morgan Stanley cut shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price target for the company. in a report on Tuesday, April 15th. Ten equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average price target of $19.60.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.